Patient notification about pragmatic clinical trials conducted with a waiver of consent: A qualitative study
While several rationales support notification about enrollment in pragmatic clinical trials conducted with waivers of consent, the relative value and practicability of notification is context-dependent. Some features, such as the need to preserve scientific validity, may appropriately weigh in favor of forgoing notification. However, evidence of divergent decision-making for similar trials suggests the need for a framework to guide future notification decisions. These data can be an important input to inform future framework development.
Authors
- Jonathan D. Casey (ORCID: https://orcid.org/0000-0001-7188-4200)
- Stephanie R. Morain (ORCID: https://orcid.org/0000-0001-7278-7517)
- Matthew W. Semler (ORCID: https://orcid.org/0000-0002-7664-8263)
- Abigail Brickler (ORCID: https://orcid.org/0009-0009-7516-218X)
Institutions
- Geisinger Medical Center (US)
- Johns Hopkins University (US)
- Johns Hopkins Berman Institute of Bioethics (US)
- Vanderbilt Health (US)
- Geisinger Health System (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Clinical Trials
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1177/17407745251377730
- Primary Topic
- Patient-Provider Communication in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00